GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (NYSE:PRGO) » Definitions » Cyclically Adjusted Price-to-FCF

Perrigo Co (Perrigo Co) Cyclically Adjusted Price-to-FCF : 9.10 (As of Apr. 27, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Perrigo Co Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Perrigo Co's current share price is $31.94. Perrigo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $3.51. Perrigo Co's Cyclically Adjusted Price-to-FCF for today is 9.10.

The historical rank and industry rank for Perrigo Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

PRGO' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 7.5   Med: 17.76   Max: 71.03
Current: 8.91

During the past years, Perrigo Co's highest Cyclically Adjusted Price-to-FCF was 71.03. The lowest was 7.50. And the median was 17.76.

PRGO's Cyclically Adjusted Price-to-FCF is ranked better than
90.15% of 325 companies
in the Drug Manufacturers industry
Industry Median: 32.81 vs PRGO: 8.91

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Perrigo Co's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $1.342. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $3.51 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Perrigo Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Cyclically Adjusted Price-to-FCF Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.51 11.53 10.53 9.35 9.17

Perrigo Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.35 10.09 9.78 9.14 9.17

Competitive Comparison of Perrigo Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Cyclically Adjusted Price-to-FCF falls into.



Perrigo Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Perrigo Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=31.94/3.51
=9.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Perrigo Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.342/120.1096*120.1096
=1.342

Current CPI (Dec. 2023) = 120.1096.

Perrigo Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 1.030 100.573 1.230
201406 1.346 100.773 1.604
201409 1.216 100.474 1.454
201412 1.874 99.576 2.260
201503 1.677 99.975 2.015
201506 0.425 100.573 0.508
201509 0.663 100.274 0.794
201512 1.020 99.676 1.229
201603 0.947 99.676 1.141
201606 0.258 101.072 0.307
201609 1.336 100.274 1.600
201612 1.286 99.676 1.550
201703 1.201 100.374 1.437
201706 0.528 100.673 0.630
201709 1.261 100.474 1.507
201712 1.292 100.075 1.551
201803 1.124 100.573 1.342
201806 0.450 101.072 0.535
201809 0.877 101.371 1.039
201812 1.090 100.773 1.299
201903 0.539 101.670 0.637
201906 0.221 102.168 0.260
201909 0.763 102.268 0.896
201912 0.308 102.068 0.362
202003 1.005 102.367 1.179
202006 1.924 101.769 2.271
202009 0.137 101.072 0.163
202012 0.325 101.072 0.386
202103 -0.336 102.367 -0.394
202106 -0.788 103.364 -0.916
202109 2.256 104.859 2.584
202112 -1.099 106.653 -1.238
202203 0.439 109.245 0.483
202206 -0.337 112.734 -0.359
202209 0.282 113.431 0.299
202212 1.183 115.425 1.231
202303 -0.028 117.618 -0.029
202306 0.241 119.611 0.242
202309 0.677 120.708 0.674
202312 1.342 120.110 1.342

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (NYSE:PRGO) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Perrigo Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (Perrigo Co) Business Description

Industry
Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Executives
Robert Willis officer: Acting CHRO C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Alison Ives officer: EVP & Chief Scientific Officer C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Eduardo Guarita Bezerra officer: EVP & Chief Financial Officer C/O FRESH DEL MONTE PRODUCE INC., PO BOX 149222, CORAL GABLES FL 33134
Patrick Lockwood-taylor director, officer: CEO C/O PERRIGO COMPANY PLC, 430 MONROE AVE NW, GRAND RAPIDS MI 49503
Julia M Brown director C/O ABLE BRANDS CO., 30 HUDSON YARDS, NEW YORK NY 10001
Triona Schmelter officer: EVP & President CSCA 2021 SPRING ROAD, SUITE 600, OAK BROOK IL 60523
Geoffrey M. Parker director 15 RIORDAN PLACE, MENLO PARK CA 94025
Svend Andersen director C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Murray S Kessler director, officer: CEO 714 GREEN VALLEY ROAD, GREENSBORO NC 27408
Thomas Farrington officer: Senior VP and CIO 4012 W. CANTERBURY CT., NEQUON WI 53092
Dillard James E Iii officer: EVP, Chief Scientific Officer 6601 WEST BROAD STREET, RICHMOND VA 23230
Ronald Craig Janish officer: EVP, Global Op. & Supply Chain PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Grainne Quinn officer: EVP, Chief Medical Officer PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Albert Manzone director C/O MERISANT, AVENUE JEAN-JACQUES ROUSSEAU 7, NEUCHATEL V8 CH-2000
Kyle Hanson officer: EVP & General Counsel